The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations
Open accessAbstract
AHCPR GRADING (continued)• dry cell battery powered continuous positive airway pressure (CPAP) machines may be required by patients with obstructive sleep apnoea on long haul flights, but they must be switched off before landing; [C] • ventilator dependent patients should inform the airline of their requirements at the time of reservation, and a doctor's letter is required outlining the medical diagnosis, necessary equipment, recent blood gas results, and ventilator settings.A medical attendant is likely to be needed.Arrangements must be made for proceeding through air terminals before and after the flight.[C](5) Logistics of air travel with oxygen: supplementary in-flight oxygen is usually prescribed at a rate of 2 l/min and should be given by nasal cannulae.In-flight oxygen need not be switched on until the plane is at cruising altitude, and may be switched off at the start of descent.For patients on oxygen at sea level, the rate should only be increased while at cruising altitude.[B] (6) In complex circumstances patients can be referred for testing in a hypobaric chamber.Centres are listed in Appendix 3.Even with in-flight oxygen, travel cannot be guaranteed to be safe.Air travel is almost always possible with appropriate medical support, but the logistics and economic costs may outweigh the benefits in individual cases. Pre-flight assessment for children• It is prudent to wait for 1 week after birth before allowing infants to fly to ensure the infant is healthy.[C] • If the infant has had any neonatal respiratory problems, the proposed journey should be discussed with a paediatrician and a hypoxic challenge test considered.[B] • For oxygen dependent children including ex-premature infants with chronic lung disease (bronchopulmonary dysplasia) where flying is imperative, oxygen requirements should be titrated in a body box [B] as follows:The infant, receiving oxygen via nasal cannulae, is placed in the body box in the company of a parent or carer, and SpO 2 monitored.The air in the body box is then diluted to 15% oxygen with nitrogen.Any fall in SpO 2 can be restored to the original value by titration of the flow of oxygen through the nasal cannulae.This flow of oxygen should then be supplied during the flight. Disease specific recommendations Asthma• Assessment is recommended as described above.• Preventative and relieving inhalers should be carried in the hand luggage.• Portable nebulisers may be used at the discretion of cabin crew.They may be connected to the aircraft electrical supply on some but not all airlines.Some airlines can provide nebulisers for in-flight use and patients should check with the carrier when booking.Spacers are as effective as nebulisers. COPD• Assessment is recommended as described above.• Passengers should travel on a non-smoking flight.• Preventative and relieving inhalers should be carried in the hand luggage.• Portable nebulisers may be used at the discretion of cabin crew.They may be connected to the aircraft electrical supply on some but not all airlines.Some airlines can provide nebulisers for in-flight use and patients should check with the carrier when booking.Spacers are as effective as nebulisers.• Patients prescribed in-flight oxygen should receive oxygen while visiting high altitude destinations (see Appendix 4).• Many airports can provide wheelchairs for transport to and from the aircraft. Cystic fibrosis• Assessment by the cystic fibrosis physician is recommended as described above.• Medications should be divided between hand and hold baggage to allow for delays and stopovers.• Portable nebulisers may be used at the discretion of cabin crew and can be connected to the aircraft electrical supply on some but not all airlines.Some airlines can provide nebulisers for in-flight use and patients should check with the carrier when booking.Spacers are as effective as nebulisers.• Passengers should undertake physiotherapy during stopovers.• In-flight nebulised antibiotics and DNase should not be necessary.• Passengers should check with their pharmacist whether any medicine may be adversely affected by extreme temperatures in the hold baggage compartment.• Many airports can provide wheelchairs for transport to and from the aircraft. Infections• Assessment is recommended as described above.• Aircraft boarding should be denied to those known to have infectious tuberculosis.• Patients with infectious tuberculosis must not travel by public air transportation until rendered non-infectious.WHO guidelines state that three smear negative sputum examinations on separate days in a person on effective antituberculous treatment indicate an extremely low potential for transmission, and a negative sputum culture result virtually precludes potential for transmission.14 This may be over-cautious.While this remains the policy for HIV positive patients, HIV negative patients who have completed 2 weeks of effective antituberculous treatment are, in practice, generally considered non-infect
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two-, six-, and 12-minute walking tests in respiratory disease.
Butland, R. J., Pang, J., Gross, E. R., Woodcock, A. A., & Geddes, D. M. (1982) · BMJ · doi:10.1136/bmj.284.6329.1607 · Cited by 1,668
Siafakas, N., Vermeire, P., Pride, N., Paoletti, P., Gibson, J., Howard, P., Yernault, J., Decramer, M., Higenbottam, T., Postma, D., et al. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081398 · Cited by 1,592
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Twelve-minute walking test for assessing disability in chronic bronchitis.
McGavin, C. R., Gupta, S. P., & McHardy, G. J. (1976) · BMJ · doi:10.1136/bmj.1.6013.822 · Cited by 742
Applied Respiratory Physiology
Nunn, J. F., & Vitkun, S. A. (1994) · Anesthesiology · doi:10.1097/00000542-199407000-00050 · Cited by 728
AN OUTBREAK OF INFLUENZA ABOARD A COMMERCIAL AIRLINER
MOSER, M. R., BENDER, T. R., MARGOLIS, H. S., NOBLE, G. R., KENDAL, A. P., & RITTER, D. G. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112781 · Cited by 605
Allergic respiratory disease: strategic targets for primary prevention during childhood
Holt, P. G., & Sly, P. D. (1997) · Thorax · doi:10.1136/thx.52.1.1 · Cited by 464
Revill, S. M., Morgan, M. D. L., Singh, S. J., Williams, J., & Hardman, A. E. (1999) · Thorax · doi:10.1136/thx.54.3.213 · Cited by 462
Scurr, J. H., Machin, S. J., Bailey-King, S., Mackie, I. J., McDonald, S., & Smith, P. D. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04645-6 · Cited by 411
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000
Joint Tuberculosis Committee of the British Thoracic Society (2000) · Thorax · doi:10.1136/thorax.55.11.887 · Cited by 366
Cited by
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
MacDuff, A., Arnold, A., Harvey, J., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136986 · Cited by 1,481
BTS guidelines for the management of spontaneous pneumothorax
Henry, M., Arnold, T., Harvey, J., & on behalf of the BTS Pleural Disease Group, A. S. O. T. B. S. O. C. C. (2003) · Thorax · doi:10.1136/thx.58.suppl_2.ii39 · Cited by 631
McKenzie, D. K., & Frith, P. A. (2003) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05213.x · Cited by 369
ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax
Tschopp, J.-M., Bintcliffe, O., Astoul, P., Canalis, E., Driesen, P., Janssen, J., Krasnik, M., Maskell, N., Van Schil, P., Tonia, T., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00219214 · Cited by 368
Metadata
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2002-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 289-304
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2428344731
- Cited by
- 263
- References
- 43
- FWCI
- 16.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. https://app.cochat.ai/papers/10.1136/thorax.57.4.289
- The paper
- Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. (2002). Thorax. https://doi.org/10.1136/thorax.57.4.289
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.